DSM Venturing, the corporate venturing unit of Netherlands-based life sciences and materials sciences company Royal DSM, has bought a “minority stake” for an undisclosed amount in Arecor, a spin-out from Anglo-Dutch consumer goods company Unilever. Arecor was spun out of the consumer goods company in 2007 and its corporate venturing unit, Unilever Ventures, was the lead investor in previous financing rounds. Many proteins, peptides or vaccines are too unstable in liquid form to develop ready-to-use drugs or are unstable at high concentrations and Arecor is collaborating with a number of pharmaceutical and biotech companies to develop differentiated formulations of recombinant proteins, monoclonal antibodies, vaccines medical devices and diagnostics. Pieter Wolters, managing director of venturing and licensing at DSM, said: “By investing in Arecor, DSM gains access to a potentially game-changing platform that may have a large effect on the bio-pharmaceutical industry.” He added by email that is was “a fresh cash investment” rather than purchase of stock from Unilever.
- News & Analysis
- Global Corporate Venturing
- Global University Venturing
- Latest News
- Deal Data
- Community & Events
Arecor stabilises with DSM
Mar 10, 2013 • Global Corporate Venturing
LEADERSHIP SOCIETYInforming, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
Featured ContentFUNDING ROUND DATA Which corporates are backing which startups? Search our corporate deal database.
FUNDING ROUND DATA
Which corporates are backing which startups? Search our corporate deal database.NOMINATE Nominations for the GCV Powerlist 2024 are now open
Nominations for the GCV Powerlist 2024 are now openEventsWebinar: Startups and Strategics – What works and what doesn’tEventsGCV Institute: Landing the Value of Corporate VenturingTop News
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.test reg